Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cesca Therapeutics Inc announces pricing of public offering of common stock


Friday, 13 Jun 2014 08:29am EDT 

Cesca Therapeutics Inc:Says the pricing of an underwritten public offering of 7,530,000 Units, consisting of an aggregate of 7,530,000 shares of the Company's common stock and warrants to purchase 2,259,000 shares of the Company's common stock, at a price of $1.50 per Unit.Each warrant entitles the holder to purchase 0.30 of a share of common stock.Warrants will be exercisable immediately upon issuance at an exercise price of $1.55 per share and will expire five years from the date of issuance.Shares of common stock and warrants comprising the Units are immediately separable.All of the Units in the offering are being sold by Cesca.Says gross proceeds to Cesca from this offering are expected to be about $11.3 mln, excluding any future proceeds from the potential exercise of the warrants and before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cesca.Says offering is expected to close on or about June 18 subject to the satisfaction of customary closing conditions.Maxim Group LLC is acting as sole book-running manager and H.C. Wainwright & Co., LLC is acting as a co-manager for the offering. 

Company Quote

1.3
-0.02 -1.52%
22 Aug 2014